Skip to content
★ Sign in to follow
CV

Cmea Ventures VI LP

Executive
Related company / holding
Intermolecular IncTetraphase Pharmaceuticals Inc
Total declarations
49
Companies
2
▲ Purchases (2 ops.)
€3.5M
▼ Sales (20 ops.)
€9.1M

Latest filing published 12 Nov 2014 for INTERMOLECULAR INC, €7.7M.

Insider track record

Disclosed buys
2
Disclosed sells
20
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Cmea Ventures VI LP: trading record in brief

This profile gathers the share dealings of Cmea Ventures VI LP across 2 companies, led by Intermolecular Inc and Tetraphase Pharmaceuticals Inc. We count 49 filings; the first trade dates from 23 November 2011 and the latest from 10 November 2014.

Market trades split into 2 purchases (€3.5M) and 20 sales (€9.1M). On balance, insiders were net sellers of €5.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2014 to date brings no purchases and 14 sales.

Most recently, on 12 November 2014, the filings show an open-market sale worth €7.7M in Intermolecular Inc. The last insider purchase was made public on 27 March 2013, 4,974 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Cmea Ventures VI LP

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations49 total

25 of 49 declarations